Popular Articles

Future Of Antiabortion-Rights Movement Uncertain In Wake Of Tiller Murder
The antiabortion-rights movement"s presence in Wichita, Kan., faces an uncertain future as its leaders re-examine their strategy after the shooting death of Kansas abortion provider George Tiller, the New York Times reports. According to the Times, Wichita has been a center for the antiabortion-rights movement for almost two decades primarily because of the location of Tiller"s clinic, which is one of the few in the U.S. that performs abortions later in pregnancy. Most notably, thousands of protesters converged on the city in the summer of 1991, known as the "Summer of Mercy," and the city is known as a "hot spot" for groups opposed to abortion rights, the Times reports. Antiabortion-rights group Operation Rescue moved its headquarters to Wichita to focus on Tiller"s clinic, and there are five other operations in the city aimed at discouraging women from having abortions. However, many groups are concerned that interest in the antiabortion-rights movement and donations in support of the cause will drop without the presence of Tiller and his patients. Troy Newman, president of Operation Rescue, said that he does not "know what the future holds" and that it is "too early to say what comes next" for the movement. He added that Scott Roeder, the man charged with Tiller"s murder, "did more to damage the pro-life movement than you can imagine."According to the Times, the antiabortion-rights movement is facing increasing backlash related to the murder, with some abortion-rights supporters saying that abortion-rights opponents" inflammatory rhetoric helped incite the violence. Mark Gietzen, president of the Kansas Coalition for Life, said that there also is disagreement among antiabortion-rights groups over whether their leaders should have issued statements condemning the murder. Tiller"s clinic currently is closed, and no patients are being given appointments, although his family said in a recent statement that it would like to continue his work, according to the Times. David Gittrich, development director of Kansans for Life, said that although Tiller"s murder will "change things in the pro-life movement ... until abortion is illegal, unthinkable and unacceptable, there"s going to be plenty of things for pro-lifers to do" (Davey, New York Times, 6/8).Justice Department Launches Federal Probe of Murder Meanwhile, the Department of Justice on Friday began a federal investigation into Tiller"s murder and is seeking to determine whether more than one person was involved in the shooting, the Times reports. Federal officials will review evidence and look into possible violations of the Freedom of Access to Clinic Entrances Act, according to DOJ. The investigation will be conducted alongside Kansas" murder prosecution. A DOJ spokesperson would not comment on whether the investigation would affect the jurisdiction in which Roeder is eventually tried (Cullotta, New York Times, 6/6).Abortion Providers, Advocates Respond to Comments from Suspect In related news, abortion-rights providers and advocates responded to Roeder"s recent comments implying that more violence against abortion providers is planned, the AP/Google.com reports. In an interview with the Associated Press, Roeder said that there are "many other similar events planned around the country as long as abortion remains legal." Roeder refused to elaborate on his statement, and law enforcement officials said that they are not sure if his statement is legitimate. LeRoy Carhart, an abortion provider who practiced at Tiller"s clinic, noted that Tiller was not the first abortion provider to be murdered, adding, "There is more than one lunatic running loose in this country that can be influenced by the religious rhetoric." Nancy Keenan, president of NARAL Pro-Choice America, said she believes it is "imperative for anti-choice groups to tone down that rhetoric and keep the more extreme elements in their movement from copying" Roeder (Hegeman, AP/Google.com, 6/8).NPR Examines FACE Act, Antiabortion ViolenceNPR"s "Morning Edition" on Friday examined th

Study Reveals Promising Natural Alternative To HRT For Menopausal Symptoms
New research, has revealed that an extract which concentrates specific nutrients from Klamath blue green algae, could provide an effective natural remedy for women looking for an effective alternative to HRT to control mood swings and improve overall wellbeing.
News of the day
Over Half Of People With Rheumatoid Arthritis Have Periodontitis
Over half (56%) of people with rheumatoid arthritis (RA) also have periodontitis (a chronic inflammatory disease of the gum and surrounding ligaments and bones that hold the teeth in place), displaying fewer teeth than healthy matched controls, high prevalence of oral sites presenting dental plaque and advanced attachment loss (the extent of periodontal support that has been destroyed around a tooth) (chi square p
Diagnostics

CSL Biotherapies Starts Shipment Of Seasonal Influenza Vaccine For The 2009-2010 Flu Season

CSL Biotherapies, a subsidiary of one of the world"s leading manufacturers of thimerosal-free seasonal influenza vaccine, announced that it has begun shipment of its seasonal influenza virus vaccine to a national network of U.S. distributors for the 2009-2010 season. CSL Biotherapies plans to deliver more than eight million doses of the vaccine, the majority of which will be in single-dose, thimerosal-free, pre-filled syringes. CSL Biotherapies" seasonal flu vaccine is indicated for the active immunization of persons age 18 years and older against influenza disease (commonly referred to as the "flu") caused by influenza virus subtypes A and type B present in the vaccine. "CSL Biotherapies" early delivery of seasonal influenza vaccine to the U.S. clearly demonstrates our ability to rapidly optimize vaccine production in order to meet evolving public health needs," said Paul Perreault, President of CSL Biotherapies. "Working with the U.S. government, we are also moving quickly to develop a vaccine to address the H1N1 pandemic. Together, these efforts illustrate the expertise in influenza vaccine development and manufacturing that CSL has so successfully accumulated over the past 40 years." CSL Limited, the parent company of CSL Biotherapies, is the first vaccine manufacturer to initiate human clinical trials of the H1N1 influenza vaccine. First administration in healthy volunteers of CSL"s experimental H1N1 pandemic vaccine began on July 22 , 2009 in Australia. U.S. clinical studies are expected to commence in mid-August. CSL Biotherapies


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):